DHP Korea Co. Ltd (131030) - Cash Flow Conversion Efficiency
Based on the latest financial reports, DHP Korea Co. Ltd (131030) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.29 Billion ≈ $3.59 Million USD) by net assets (₩150.47 Billion ≈ $101.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DHP Korea Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how DHP Korea Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read DHP Korea Co. Ltd (131030) total liabilities for a breakdown of total debt and financial obligations.
DHP Korea Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DHP Korea Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Les Docks des Pétroles d'Ambès -SA
PA:DPAM
|
0.034x |
|
Manoj Vaibhav Gems 'N' Jewellers Limited
NSE:MVGJL
|
0.128x |
|
Kabra Extrusion Technik Limited
NSE:KABRAEXTRU
|
-0.022x |
|
Lakeland Industries Inc
NASDAQ:LAKE
|
-0.023x |
|
Strix Group Plc
F:SG9
|
N/A |
|
Daesung Holdin
KO:016710
|
-0.019x |
|
Seanergy Maritime Holdings Corp
F:RHSR
|
0.037x |
|
ATM Grupa S.A.
WAR:ATG
|
0.012x |
Annual Cash Flow Conversion Efficiency for DHP Korea Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of DHP Korea Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see 131030 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩143.73 Billion ≈ $97.41 Million |
₩8.90 Billion ≈ $6.03 Million |
0.062x | -33.03% |
| 2023-12-31 | ₩134.45 Billion ≈ $91.12 Million |
₩12.44 Billion ≈ $8.43 Million |
0.093x | +462.97% |
| 2022-12-31 | ₩124.47 Billion ≈ $84.35 Million |
₩2.05 Billion ≈ $1.39 Million |
0.016x | -70.48% |
| 2021-12-31 | ₩127.02 Billion ≈ $86.08 Million |
₩7.07 Billion ≈ $4.79 Million |
0.056x | -62.06% |
| 2020-12-31 | ₩118.88 Billion ≈ $80.57 Million |
₩17.45 Billion ≈ $11.82 Million |
0.147x | -6.05% |
| 2019-12-31 | ₩107.75 Billion ≈ $73.02 Million |
₩16.83 Billion ≈ $11.41 Million |
0.156x | -1.48% |
| 2018-12-31 | ₩94.90 Billion ≈ $64.31 Million |
₩15.05 Billion ≈ $10.20 Million |
0.159x | -25.02% |
| 2017-12-31 | ₩86.55 Billion ≈ $58.66 Million |
₩18.30 Billion ≈ $12.40 Million |
0.211x | +32.18% |
| 2016-12-31 | ₩75.26 Billion ≈ $51.00 Million |
₩12.04 Billion ≈ $8.16 Million |
0.160x | -5.44% |
| 2015-12-31 | ₩65.49 Billion ≈ $44.38 Million |
₩11.08 Billion ≈ $7.51 Million |
0.169x | -25.43% |
| 2014-12-31 | ₩56.49 Billion ≈ $38.28 Million |
₩12.82 Billion ≈ $8.69 Million |
0.227x | -- |
About DHP Korea Co. Ltd
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company… Read more